Onpoint Nyc, Inc.

New York, NY

UEI
M5PSMU1T6W37
CAGE
72ZA2
Primary NAICS
Not on record
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
Entity structure
Corporate Entity (Tax Exempt)
SAM.gov registration date
Physical address
104 E 126th St #3B, New York, NY 10035, USA
Website
onpointnyc.org
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Consumer Discretionary
  2. Consumer Services
  3. Diversified Consumer Services
  4. Specialized Consumer Services
SIC code
86 Membership Organizations
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Grant subawards

Prime recipient Prime award Amount Awarded
Addiction Services & Supports New York State Office Of Street Outreach B08TI083958 $456,130
Addiction Services & Supports New York State Office Of Substance Use Disorder Program Street Outreach B08TI083539 $49,630

Similar vendors

About the company

Onpoint Nyc, Inc., a New York City-based nonprofit organization, receives federal grant funding as a prime recipient for harm reduction and medication-assisted treatment (MAT) services delivered to people who use drugs in Northern Manhattan and the South Bronx. The organization operates under two prime SAMHSA grants and participates as a sub-recipient on a third grant from the New York State Office of Addiction Services & Supports.

Onpoint Nyc's federal footprint is concentrated entirely within the Department of Health and Human Services, specifically the Substance Abuse and Mental Health Services Administration (SAMHSA). All four awards in the source data — two prime grants and two sub-awards — flow from SAMHSA or SAMHSA-funded state intermediaries, accounting for $6.2 million in combined dollars obligated across the portfolio. The organization's two primary grants are both project-grant awards: a New York Harm Reduction Educators (NYHRE) Harm Reduction Program grant awarded May 30, 2022 (ultimate completion May 29, 2025) providing overdose prevention, syringe services, HIV/HCV testing and treatment, vaccination, mental health services, and connections to housing and food assistance; and a Community-Based MAT grant awarded September 30, 2021 (ultimate completion September 29, 2025) focusing on low-threshold medication-assisted treatment for opioid use disorder in East Harlem and the South Bronx, with integrated mental health treatment for co-occurring conditions. Both grants target racial and ethnic minorities, with at least 80 percent of participants expected to be Black or Latino. Onpoint Nyc also serves as a sub-recipient on a Street Outreach grant from the New York State Office of Addiction Services & Supports, awarded September 1, 2023.

Award activity has been sparse and declining — two awards in 2021, one in 2022, and one in 2023 — with no new awards captured in the source data since September 2023. Both prime grants reach ultimate completion by September 2025, creating recompete opportunity for SAMHSA funding in that window.

Quick answers

Is Onpoint Nyc, Inc. registered in SAM.gov?

Onpoint Nyc, Inc.'s SAM.gov registration expired on June 3, 2026.

What is Onpoint Nyc, Inc.'s most recent federal award?

Onpoint Nyc, Inc.'s most recent federal grant award is Nyhre harm reduction program (H79SP083924), from SAMHSA Division of Grants Management, on May 30, 2022.

On GovTribe

See Onpoint Nyc, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors